Most Improved
The largest Index Score™ gains since the previous review cycle. Improvement is measured, not claimed.
| Rank | Company | Tier | Index Score™ | Trend |
|---|---|---|---|---|
| 1 · rank 1 | Among the strongest purity results of the 2026 cycle. | Excellent | 87/100 BioRegen Research: Index Score 87 out of 100, Excellent | no change |
| 2 · rank 2 | Good | 79/100 Helix Research Supply: Index Score 79 out of 100, Good | no change | |
| 3 · rank 3 | Good | 70/100 Vector Peptide Supply: Index Score 70 out of 100, Good | no change | |
| 4 | Excellent | 85/100 Atlas Peptide Labs: Index Score 85 out of 100, Excellent | no change | |
| 5 | Exceptional | 90/100 Research Peptides Co.: Index Score 90 out of 100, Exceptional | no change | |
| 6 | Exceptional | 91/100 Apex Peptides: Index Score 91 out of 100, Exceptional | no change | |
| 7 | Most complete manufacturing disclosure we track. | Excellent | 89/100 PureSci Labs: Index Score 89 out of 100, Excellent | no change |
| 8 | Good | 74/100 Sterling Compound Co.: Index Score 74 out of 100, Good | no change | |
| 9 | Excellent | 87/100 Cardinal Metabolic Clinic: Index Score 87 out of 100, Excellent | no change | |
| 10 | Excellent | 89/100 Halcyon Biosciences: Index Score 89 out of 100, Excellent | no change |